ManagementThe guys on top are there for a reason, there is no point bashing them every now and then. For me personally their success was getting the guys from Boston before the biogen Judegment day and the gamble to align ourselves with aducanumab kind of paid off. I do hate the fact that they don't stick to the timeliness they provide and thankfully they have the forward looking statement disclosure to hide behind. -Waiting for an update on Serology , probably the most disappointing work yet by promis. We were all told that this would be ready by last summer and expected revenues q4 2020. I hope we had some way of keeping them accountable. We all know this has potential and now it's been validated. When this happens it will be huge for sure, but my hopes for some sp action happening this quarter is dead. Happy Weekend